Cargando…

Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma Patients

OBJECTIVE: Antithyroglobulin antibodies (TgAbs) could be used as a surrogate tumor marker of TgAb-positive-differentiated thyroid carcinoma. This study aims to determine whether the change in TgAb levels over time could be used as a predictor of responses to therapy in pediatric papillary thyroid ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Chuang, Zhang, Guo-Qiang, Song, Hong-Jun, Shen, Chen-Tian, Hou, Li-Ying, Qiu, Zhong-Ling, Luo, Quan-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930237/ https://www.ncbi.nlm.nih.gov/pubmed/35311033 http://dx.doi.org/10.1155/2022/7173919

Ejemplares similares

Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China
por: Liu, Qianhui, et al.
Publicado: (2021)

Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
por: Kimbara, Shiro, et al.
Publicado: (2018)

Corrigendum: Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China
por: Liu, Qianhui, et al.
Publicado: (2022)

Association of antithyroglobulin antibody with iodine nutrition and thyroid dysfunction in Nepalese children
por: Tamang, Binaya, et al.
Publicado: (2019)

Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer
por: Dewi, Ayu Rosemeilia, et al.
Publicado: (2017)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018)

Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study
por: Ora, Manish, et al.
Publicado: (2021)

Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy()
por: Côrtes, Marina Carvalho S., et al.
Publicado: (2017)

Estimation of True Serum Thyroglobulin Concentration Using Simultaneous Measurement of Serum Antithyroglobulin Antibody
por: Ahn, Byeong-Cheol, et al.
Publicado: (2013)

Dynamic Changes in Antithyroperoxidase and Antithyroglobulin Antibodies Suggest an Increased Risk for Abnormal Thyrotropin Levels
por: Li, Yongze, et al.
Publicado: (2020)

Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer
por: Neshandar Asli, Isa, et al.
Publicado: (2014)

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation
por: Zavala, Luis Felipe, et al.
Publicado: (2019)

Serum Antithyroglobulin Antibody Levels Are Associated with Diabetic Retinopathy among Euthyroid Type 2 Diabetes Patients: A Hospital-Based, Retrospective Study
por: Gao, Xiaotong, et al.
Publicado: (2022)

Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study
por: Han, Na, et al.
Publicado: (2023)

A Study on Serum Antithyroglobulin Antibodies Interference in Thyroglobulin Measurement in Fine-Needle Aspiration for Diagnosing Lymph Node Metastasis in Postoperative Patients
por: Shin, Hyun Joo, et al.
Publicado: (2015)

Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of (131)I Therapy in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy: A Retrospective Study
por: Pan, Mengjiao, et al.
Publicado: (2022)

Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
por: Qiu, Zhong-Ling, et al.
Publicado: (2020)

An Autobiographical Case Report on Papillary Thyroid Carcinoma with Positive Antithyroid Antibodies: Coincidence or Correlated?
por: Singh, Arkaja, et al.
Publicado: (2023)

Thyroid Function and Anti-thyroid Antibodies in Pediatric Anti-NMDAR Encephalitis
por: Chen, Lianfeng, et al.
Publicado: (2021)

Positive thyroid antibodies and risk of thyroid cancer: A systematic review and meta-analysis
por: Xiao, Yang, et al.
Publicado: (2019)

Transiently impaired endothelial function during thyroid hormone withdrawal in differentiated thyroid cancer patients
por: Hou, Li-ying, et al.
Publicado: (2023)

Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma
por: Liu, Mei-juan, et al.
Publicado: (2017)

Evaluation of the VE1 Antibody in Thyroid Cytology Using Ex Vivo Papillary Thyroid Carcinoma Specimens
por: Kim, Yon Hee, et al.
Publicado: (2016)

ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma
por: Zhang, Peng, et al.
Publicado: (2023)

Blood prognostic predictors of treatment response for patients with papillary thyroid cancer
por: Liu, Xiangxiang, et al.
Publicado: (2020)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

The association between thyroid-stimulating hormone and thyroid nodules, goiter and thyroid antibody positivity
por: Li, Shaohan, et al.
Publicado: (2023)

Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 Cases
por: Wang, Weibin, et al.
Publicado: (2022)

The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
por: Li, Yangsen, et al.
Publicado: (2022)

Antithyroid Antibodies and Thyroid Function in Pediatric Patients with Celiac Disease
por: Kalyoncu, Derya, et al.
Publicado: (2015)

Association between metabolic syndrome and clinicopathological features of papillary thyroid cancer
por: Song, Jun-Long, et al.
Publicado: (2021)

Pediatric papillary thyroid cancer: current management challenges
por: Verburg, Frederik A, et al.
Publicado: (2016)

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
por: Mehnert, Janice M., et al.
Publicado: (2019)

The ABCs of finding a good antibody: How to find a good antibody, validate it, and publish meaningful data
por: Acharya, Poulomi, et al.
Publicado: (2017)

Treatment for papillary thyroid microcarcinoma
por: Shi, Lan, et al.
Publicado: (2013)

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
por: Xing, Zhichao, et al.
Publicado: (2021)

Epidemiology of Hypothyroidism, Hyperthyroidism and Positive Thyroid Antibodies in the Croatian Population
por: Strikić Đula, Ivana, et al.
Publicado: (2022)

The first pediatric anti-lactosylceramide antibody-positive encephalomyeloradiculoneuropathy
por: Sasaki, Akiko, et al.
Publicado: (2022)

Anemia, hematinic deficiencies, and hyperhomocysteinemia in burning mouth syndrome patients with thyroglobulin antibody/thyroid microsomal antibody positivity but without gastric parietal cell antibody positivity
por: Jin, Ying-Tai, et al.
Publicado: (2022)

Anti-thyroid antibodies, parietal cell antibodies and tissue transglutaminase antibodies in patients with autoimmune thyroid disease
por: Twito, Orit, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_72ladupmt0vc17jctso13ivh45